NovMetaPharma Market Cap

NovMetaPharma has a market cap or net worth of 136.63 billion as of February 20, 2026. Its market cap has increased by 125.80% in one year.

Market Cap

136.63B

Enterprise Value

n/a

Revenue

1.30B

Ranking

n/a

PE Ratio

89.58

Stock Price

11,410.00

Market Cap Chart

Since April 5, 2017, NovMetaPharma's market cap has increased from 74.59B to 136.63B, an increase of 83.17%. That is a compound annual growth rate of 7.05%.

Market Cap History

Date	Market Cap	% Change
Feb 20, 2026	136.63B	-16.53%
Dec 30, 2025	163.69B	187.16%
Dec 30, 2024	57.00B	-46.33%
Dec 29, 2022	106.21B	-45.89%
Dec 30, 2021	196.29B	-9.50%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Apr 5, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
QuadMedicine	208.23B
Kangstem Biotech	206.45B
Ensol Biosciences	201.99B
TiumBio	181.16B
CORESTEMCHEMON	165.91B
ViGenCell	162.97B
BIO-FD&C	136.78B
TegoScience	113.69B

Market Cap Rankings